![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
||||||||||||||||
![]() |
||||||||||||||||||||||
|
|
||||||||||||||||||||||
| Anika Therapeutics, Inc. develops, manufactures and commercializes therapeutic products intended to repair, protect and heal bone, cartilage and soft tissue. Our products are based on hyaluronic acid (HA), a biocompatible polymer found throughout the body that enhances joint function and coats, protects, cushions and lubricates soft tissues. Anika's current commercial products focus on ophthalmic surgery, cosmetic dermatology, surgical anti-adhesion and osteoarthritis conditions. Active new product development initiatives focus on novel HA formulations in these and other applications. |
||||||||||||||||||||||
![]() |
||||||||||||||||||||||
| Anika has considerable knowledge and expertise in the formulation and manufacturing of naturally derived HA. Our extraction and purification processes enable us to produce a premium-grade, ultra-pure, highly concentrated HA that has high molecular weight and viscocity, supporting both the efficacy and safety of our products. A public company since 1993, Anika is headquartered in Woburn, Massachusetts. | ||||||||||||||||||||||
|
||||||||||||||||||||||